Cube Biotech
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Revenues | - | - | 1.0m | 1.0m | 1.3m |
% growth | - | - | - | - | 30 % |
Profit | <1m | (<1m) | <1m | <1m | <1m |
% profit margin | - | - | 23 % | 78 % | 38 % |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Series A | ||
N/A | Buyout | ||
Total Funding | - |
Related Content
Recent News about Cube Biotech
EditCube Biotech specializes in providing customized protein services and bead functionalization, catering primarily to researchers and institutions involved in membrane protein research. Operating in the biotechnology sector, Cube Biotech offers a range of products and services including affinity chromatography magnetic beads, protein purification kits, and membrane protein stabilization solutions. The company generates revenue through the sale of these specialized products and custom services, which are designed to accelerate research and development processes in the field of proteomics and drug discovery. Cube Biotech serves over 100 institutions worldwide, leveraging its team's extensive experience in membrane protein expression, purification, and crystallization to deliver high-quality solutions. The business model focuses on addressing the specific needs of researchers by offering tailored solutions that save time and resources, thereby enhancing the efficiency of scientific investigations.
Keywords: protein services, bead functionalization, membrane proteins, affinity chromatography, protein purification, proteomics, drug discovery, custom solutions, biotechnology, research institutions.